Where are GlaxoSmithKline’s artificial intelligence efforts headed? John Baldoni knows; he leads the company’s internal AI unit. In this interview, he discusses the company’s machine-driven discovery and development methods and how they can save time and money. “There’s a lot of failure there. If you can reduce that failure by just a little bit you’re creating a lot of value and you help that organization win the race to the clinic,” Baldoni says. Find out how. Gain insights into the AI team’s timeline and what it has accomplished already. Learn who GSK’s partners are, and discover why GSK is putting all its AI experiments in one business unit.